Observational studyAnais brasileiros de dermatologia
Longitudinal analysis of hospital morbidity and mortality due to skin cancer from 2012 to 2022: comparison with demographic and geographic factors in Brazilian states.
Observational study in Anais brasileiros de dermatologia. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSkin cancer is the most common neoplasm among Brazilians, accounting for 31.3% of all cancer cases in the country.
objectivesTo analyze the longitudinal morbimortality of skin cancer and compare it with the latitude and the prevalence of white skin color in each federative unit of the country.
methodsAn ecological observational study was carried out using data from the Hospital Information System (SIH) and the Mortality Information System (SIM).
resultsIn Brazil, morbidity rates (per 100,000 inhabitants) increased from 14.88 to 27.69 (p < 0.05) when comparing the years 2012 and 2022, whereas the mortality rates (per 100,000 inhabitants) increased from 0.35 to 0.54 (p < 0.05) during the same period. Furthermore, most states showed an increase in morbimortality rates. Concerning race/ethnicity, individuals with white skin had the highest morbimortality rates. Regarding the age groups, individuals over 50 years old had the highest morbidity rates, while patients over 80 years old had the highest mortality rates, at 23.29%. Finally, the latitude showed a negative correlation, meaning that lower latitudes presented higher rates of morbidity and mortality from skin cancer. STUDY LIMITATIONS: Self-reporting of skin color by participants, which may not fully correspond to phototypes. Data was analyzed exclusively from hospitalizations through the Unified Health System (SUS) and severe cases of the disease, as this study focused on hospitalizations and mortality, considering that the main treatment for skin cancer is carried out on an outpatient basis.
conclusionsThe majority of Brazilian states showed rising morbimortality rates during the period, with the white-skinned population being the most affected. Additionally, a negative correlation with latitude was observed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.